Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease

NCT03775096 is registered in ClinicalTrials.gov with Michele Tagliati, MD as lead sponsor.

NCT NCT03775096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03775096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease
Lead sponsor
Michele Tagliati, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 4, 2019
Completion date
July 1, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-motor parkinson disease, rem sleep behavior disorder, symptomatic parkinson disease